Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 13, Pages 3249-3254
Publisher
Proceedings of the National Academy of Sciences
Online
2018-03-13
DOI
10.1073/pnas.1719190115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Nature and Reactivity of Ferryl Heme in Compounds I and II
- (2018) Peter C. E. Moody et al. ACCOUNTS OF CHEMICAL RESEARCH
- Development of a series of novel o -phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
- (2018) David K. Williams et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate
- (2017) Stefano Crosignani et al. JOURNAL OF MEDICINAL CHEMISTRY
- In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control ofMycobacterium tuberculosis
- (2017) Uma S. Gautam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1
- (2017) Ariel Lewis-Ballester et al. Nature Communications
- Analysis of Reaction Intermediates in Tryptophan 2,3-Dioxygenase: A Comparison with Indoleamine 2,3-Dioxygenase
- (2016) Jaswir Basran et al. BIOCHEMISTRY
- Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications
- (2016) Lucía Álvarez et al. BIOCHEMISTRY
- O-alkylhydroxylamines as rationally-designed mechanism-based inhibitors of indoleamine 2,3-dioxygenase-1
- (2016) William P. Malachowski et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
- (2016) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Substrate Oxidation by Indoleamine 2,3-Dioxygenase
- (2015) Elizabeth S. Booth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
- (2015) Ute F. Röhrig et al. JOURNAL OF MEDICINAL CHEMISTRY
- Heme-thiolate ferryl of aromatic peroxygenase is basic and reactive
- (2015) Xiaoshi Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
- (2015) Nicolas van Baren et al. Frontiers in Immunology
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
- (2014) Richard Metz et al. INTERNATIONAL IMMUNOLOGY
- The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
- (2012) Igor Efimov et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- (2012) David H. Munn et al. TRENDS IN IMMUNOLOGY
- IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
- (2012) Richard Metz et al. OncoImmunology
- Oxidation and Loss of Heme in Soluble Guanylyl Cyclase fromManduca sexta
- (2011) Bradley G. Fritz et al. BIOCHEMISTRY
- The Mechanism of Formation ofN-Formylkynurenine by Heme Dioxygenases
- (2011) Jaswir Basran et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structure of Cinaciguat (BAY 58–2667) Bound toNostocH-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl Cyclase
- (2010) Faye Martin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kynurenine is an endothelium-derived relaxing factor produced during inflammation
- (2010) Yutang Wang et al. NATURE MEDICINE
- Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease
- (2010) D. Favre et al. Science Translational Medicine
- Inhibitory Substrate Binding Site of Human Indoleamine 2,3-Dioxygenase
- (2009) Changyuan Lu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Evidence for a ferryl intermediate in a heme-based dioxygenase
- (2009) A. Lewis-Ballester et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
- (2008) A. Curti et al. BLOOD
- Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase
- (2008) A. J. Muller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started